课题基金 / 基金详情

Molecular mechanism of ATP-dependent copper transporters

Molecular mechanism of ATP-dependent copper transporters
ATP依赖性铜转运蛋白的分子机制
批准号:
6958723
负责人:
SVETLANA LUTSENKO
金额:
$30.87万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2010-07-31

项目摘要

项目成果

SVETLANA LUTSENKO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of these studies is to understand the fundamental mechanisms that regulate the concentration of copper in human cells. Copper plays an essential role in human physiology and is required for embryonic development, respiration, neurotransmitter biosynthesis, and other important physiological processes. Human copper-transporting ATPases ATP7A and ATP7B play a central role in the regulation of intracellular copper. Mutations in these transporters result in the severe metabolic disorders, Menkes disease and Wilson's disease, respectively. Recent studies also suggest that ATP7A (Menkes disease protein, MNKP) and ATP7B (Wilson's disease protein, WNDP) are involved in cellular resistance to platinumbased chemotherapeutic drugs, and therefore could be important pharmacological targets in cancer treatment. Despite the essential role of MNKP and WNDP in human physiology, our knowledge of how these ATP-driven transporters regulate intracellular copper is extremely limited. In the proposed series of experiments, a unique set of biochemical tools established by the PI's laboratory is utilized to dissect specific molecular mechanisms that control the function and regulation of WNDP and MNKP in cells. Four specific aims are proposed. The first objective is to generate a comprehensive picture of copper-dependent regulation of WNDP and MNKP by characterizing the functional roles of the multiple metal-binding sites in the N-terminal domain of these proteins. The second goal is to obtain structural information necessary for an understanding of nucleotide binding by WNDP and MNKP and for the development of specific inhibitors for these transporters. Thirdly, the role of a recently discovered protein Murr1 in the function and regulation of WNDP will be determined using a combination of biochemical and cell biological approaches. The final objective is to dissect the molecular mechanism of the MNKP/WNDP-related cisplatin resistance. These studies will yield important mechanistic information about the regulation of copper in human cells and will contribute to a better understanding and treatment of disorders associated with copper misbalance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HUMAN DISORDERS OF COPPER METABOLISM: RECENT ADVANCES AND MAIN CHALLENGES
  • 批准号:
    8459097
  • 项目类别:
  • 资助金额:
    $1.9万
  • 财政年份:
    2013
  • 负责人:
    SVETLANA LUTSENKO
  • 依托单位:
Integrative Analysis of Wilson's Disease
  • 批准号:
    9448230
  • 项目类别:
  • 资助金额:
    $43.06万
  • 财政年份:
    2012
  • 负责人:
    SVETLANA LUTSENKO
  • 依托单位:
Integrative Analysis of Wilson's Disease
  • 批准号:
    8523921
  • 项目类别:
  • 资助金额:
    $37.29万
  • 财政年份:
    2012
  • 负责人:
    SVETLANA LUTSENKO
  • 依托单位:
Integrative Analysis of Wilson's Disease
  • 批准号:
    8669996
  • 项目类别:
  • 资助金额:
    $38.17万
  • 财政年份:
    2012
  • 负责人:
    SVETLANA LUTSENKO
  • 依托单位:
国内基金
海外基金
Perry syndrome相关蛋白p150glued调控黑质多巴胺能神经元功能和变性的机制
  • 批准号:
    81601117
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2016
  • 负责人:
    于佳
  • 依托单位:
天使症候群(Angelman Syndrome,AS)TrkB信号损伤的机制研究及靶向干预
  • 批准号:
    31371139
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    曹聪
  • 依托单位:
p73在Hutchinson-Gilford Progeria Syndrome 中对DNA损伤修复通路调控的机制研究
  • 批准号:
    81300258
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    汤慧
  • 依托单位:
新的Peutz-Jeghers Syndrome 致病基因的定位与克隆
  • 批准号:
    30240062
  • 项目类别:
    专项基金项目
  • 资助金额:
    7.0万元
  • 批准年份:
    2002
  • 负责人:
    李宜雄
  • 依托单位: